An interventional study of Hyperbaric Oxygen Therapy in Hyperbaric Oxygenation, Oxygen Toxicity and Antioxidants, sponsored by Nicolaus Copernicus University. Completed at 1 site in Poland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-07.
Sponsored by Nicolaus Copernicus University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of the research project was to investigate the effects of hyperbaric oxygen (HBO) treatment on the redox equilibrium in individuals with different pathological conditions. Both hyperbaric oxygenation and the pathological condition are associated with redox imbalance (oxidative stress), however, HBO is successfully used in the treatment of chronic wounds, e.g., diabetic foot syndrome, as well as in sudden and acute hearing loss, e.g., acute acoustic trauma or idiopathic sudden sensorineural hearing loss.
The study involed in sudden sensorineural hearing loss (SSNHL) patients, individuals with difficult-to-heal skin wounds following mechanical injuries, and diabetic foot patients. HBO therapy, which involved inhalation of 100% oxygen at a pressure of 2.5 atm, consisted of 14-30 sessions depending on the clinical case. The study material was venous blood drawn three times: before and after the first session, and after the last HBO procedure. The following variables were evaluated: the concentrations of thiobarbituric acid reactive substances (TBARS), malondialdehyde (MDA) and conjugated dienes (CD) in plasma and erythrocytes, the activities of catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) in erythrocytes, as well as, blood counts.
Nicolaus Copernicus University is the lead sponsor of 19 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hyperbaric oxygen (HBO) therapy.
Procedure: Hyperbaric Oxygen Therapy
Healthy individuals that never treated with HBO therapy.
HBO session includes three 20-minute inhalations of pure oxygen in a hyperbaric chamber utilizing specially fitted face masks for each patient. The session is conducted as follows: 10 minutes compression of up to 2.5 atm (0.25 MPa), inhalation of 100% oxygen for 20 minutes, a 5-minute break in the chamber without the mask (oxygen concentration up to 23%, constant temperature (room) and humidity), again 20 minutes inhalation of 100% oxygen, another 5-minute break (the same condition), the last 20 minutes inhalation of 100% oxygen, and finally a 10-minute decompression. The total duration of the session was 90 minutes.
Also known as: HBO treatment, Hyperbaric Oxygenation
Thiobarbituric acid reactive substances (TBARS)
Lipid peroxidation index represented by malondialdehyde (MDA), determined in plasma and erythrocytes.
Time frame: Three days, three different condition measurements
Malondialdehyde (MDA)
Lipid peroxidation index; pure MDA determined using high-performance liquid chromatography in plasma and erythrocytes.
Time frame: Three days, three different condition measurements
Conjugated dienes (CD)
Lipid peroxidation index, determined in plasma and erythrocytes.
Time frame: Three days, three different condition measurements
Catalase (CAT)
Antioxidant enzyme, determined in erythrocytes.
Time frame: Three days, three different condition measurements
Superoxide dismutase (SOD)
Antioxidant enzyme, determined in erythrocytes.
Time frame: Three days, three different condition measurements
Glutathione peroxidase (GPx)
Antioxidant enzyme, determined in erythrocytes.
Time frame: Three days, three different condition measurements
White blood cell count (WBC)
Leukocytes found in peripheral blood with specyfication of their types: lymphocytes, monocytes, neutrophils, eosinophils, basophils.
Time frame: Two days, two different condition measurements
Red blood cell count (RBS)
Erythrocytes found in peripheral blood.
Time frame: Two days, two different condition measurements
Hemoglobin (HGB)
Mean concentration of hemoglobin in the blood.
Time frame: Two days, two different condition measurements
Hematocrit (HCT)
The percentage of red blood cells in the blood.
Time frame: Two days, two different condition measurements
Mean corpuscular volume (MCV)
Mean volume of erythrocytes in the blood.
Time frame: Two days, two different condition measurements
Mean corpuscular hemoglobin (MCH)
Mean mass of hemoglobin in an erythrocyte.
Time frame: Two days, two different condition measurements
Mean corpuscular hemoglobin concentration (MCHC)
MCH expressed in a unit of blood volume.
Time frame: Two days, two different condition measurements
Red cell distribution width (RDW)
Differences in the volume and size of erythrocytes.
Time frame: Two days, two different condition measurements
Platelets (PLT)
Thrombocytes found in peripheral blood.
Time frame: Two days, two different condition measurements
Plateletcrit (PCT)
Volume occupied by platelets in the blood.
Time frame: Two days, two different condition measurements
Mean platelet volume (MPV)
Mean volume of thrombocytes in the blood.
Time frame: Two days, two different condition measurements
Platelet distribution width (PDW)
Measurement of platelet anisocytosis calculated from the distribution of individual platelet volumes.
Time frame: Two days, two different condition measurements
Plan to share: No — There is no individual participant data (IPD) sharing plan.
No publications or documents are linked to this record.
Ran from Apr 2016 to primary completion in Dec 2020, 56 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nicolaus Copernicus University